Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

36
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
36

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

3D-Printed Precision Porous Scaffolds Promote Healing In Vivo.

Journal of biomedical materials research. Part A·2025
Same author

Gene therapy for intracranial aneurysms: systemic review.

Journal of neurointerventional surgery·2024
Same author

Dialysate regeneration via urea photodecomposition with TiO<sub>2</sub> nanowires at therapeutic rates.

Artificial organs·2023
Same author

Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.

Advanced healthcare materials·2021
Same author

Uniform 40-µm-pore diameter precision templated scaffolds promote a pro-healing host response by extracellular vesicle immune communication.

Journal of tissue engineering and regenerative medicine·2020
Same author

An interview with Buddy Ratner.

Therapeutic delivery·2020

相关实验视频

Updated: Jul 13, 2025

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

8.3K

血管移植:技术成功/技术失败

Buddy Ratner1

  • 1Center for Dialysis Innovation (CDI), Departments of Bioengineering and Chemical Engineering, University of Washington, Seattle, WA 98195, USA.

BME frontiers
|October 18, 2023
PubMed
概括

开发直径小的血管移植 (VSVG) 仍然是一个挑战. 这种观点认为,导致纤维囊的"生物相容"材料阻碍了VSVG的成功,这表明前期愈合材料可能提供解决方案.

科学领域:

  • 生物材料科学 生物材料科学
  • 血管外科 血管外科
  • 再生医学是一种再生医学.

背景情况:

  • 血管假肢 (移植) 对各种手术应用至关重要,包括血液透析接入,创伤和动脉瘤修复.
  • 尽管进行了广泛的研究,但实现功能性小直径 (≤4毫米) 血管移植仍然是一个重大挑战.
  • 目前的移植通常会引起纤维化封装反应,从而限制其长期疗效.

研究的目的:

  • 提出一种新的假设,以克服小直径血管移植发育的局限性.
  • 批判性地审查现有的血管移植文献,并确定影响移植性能的关键因素.
  • 提出一个新的研究方向,专注于"预愈合"生物材料.

主要方法:

  • 血管移植文献和材料类型的历史审查.
  • 对植入生物材料的封装和血管化反应的分析.
  • 纤维化封装与具有血管性的组织重建的比较检查.

主要成果:

  • 该假设认为,常用的"生物相容"生物材料,诱导密集的,非血管化的原囊,可能不是真正的生物相容.
  • 促进组织重建和血管化的材料,而不是纤维化封装,提供了一个对比的治疗范式.
  • 这种区别凸显了目前用于血管移植的生物材料选择的潜在缺陷.

更多相关视频

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:19

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

284
Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

11.8K

相关实验视频

Last Updated: Jul 13, 2025

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

8.3K
Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:19

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

284
Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

11.8K

结论:

  • 血管移植材料的"生物相容性"需要重新评估,超越惰性封装.
  • 促进真正组织整合和血管化的材料对于成功开发小直径血管移植是必不可少的.
  • 这种观点可能会指导新一代血管移植的创建,用于具有挑战性的重建.